About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 697237, 7 pages
http://dx.doi.org/10.1155/2012/697237
Review Article

Outcome Measures of Chinese Herbal Medicine for Hypertension: An Overview of Systematic Reviews

Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China

Received 11 November 2012; Accepted 10 December 2012

Academic Editor: Tabinda Ashfaq

Copyright © 2012 Jie Wang and Xingjiang Xiong. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Sliwa, S. Stewart, and B. J. Gersh, “Hypertension: a global perspective,” Circulation, vol. 123, no. 24, pp. 2892–2896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. MacMahon, M. H. Alderman, L. H. Lindholm, L. Liu, R. A. Sanchez, and Y. K. Seedat, “Blood-pressure-related disease is a global health priority,” The Lancet, vol. 371, no. 9623, pp. 1480–1482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, “Global burden of hypertension: analysis of worldwide data,” Lancet, vol. 365, no. 9455, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Xu and K. J. Chen, “Complementary and alternative medicine: is it possible to be mainstream?” Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 403–404, 2012. View at Publisher · View at Google Scholar
  6. A. Weil, “The state of the integrative medicine in the U.S. and Western World,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 6–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Keji and X. Hao, “The integration of traditional Chinese medicine and Western medicine,” European Review, vol. 11, no. 2, pp. 225–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Cheung, “TCM: made in China,” Nature, vol. 480, no. 7378, supplement, pp. S82–S83, 2011.
  9. H. Xu and K. Chen, “Integrative medicine: the experience from China,” Journal of Alternative and Complementary Medicine, vol. 14, no. 1, pp. 3–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Robinson, “Integrative medicine—traditional Chinese medicine, a model?” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 21–25, 2011. View at Publisher · View at Google Scholar
  11. K. J. Chen, “Where are we going?” Chinese Journal of Integrative Medicine, vol. 16, no. 2, pp. 100–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Dobos and I. Tao, “The model of western integrative medicine: the role of Chinese medicine,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 11–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Eisenberg, “Reflections on the past and future of integrative medicine from a lifelong student of the integration of Chinese and Western medicine,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 3–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. X. G. Sun, W. K. Wu, and Z. P. Lu, “Chinese integrative medicine: translation toward person centered and balanced medicine,” Chinese Journal of Integrative Medicine, vol. 18, no. 1, pp. 3–6, 2012. View at Publisher · View at Google Scholar
  15. J. Wang, P. Q. Wang, and X. J. Xiong, “Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine,” Internal Medicine, vol. 2, no. 3, 2012. View at Publisher · View at Google Scholar
  16. H. Xu and K. J. Chen, “Integrating traditional medicine with biomedicine towards a patient-centered healthcare system,” Chinese Journal of Integrative Medicine, vol. 17, no. 2, pp. 83–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Wang and X. J. Xiong, “Current situation and perspectives of clinical study in integrative medicine in China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 268542, 11 pages, 2012. View at Publisher · View at Google Scholar
  18. R. A. Bell, C. K. Suerken, J. G. Grzywacz, W. Lang, S. A. Quandt, and T. A. Arcury, “CAM use among older adults age 65 or older with hypertension in the United States: general use and disease treatment,” Journal of Alternative and Complementary Medicine, vol. 12, no. 9, pp. 903–909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Ernst, “Complementary/alternative medicine for hypertension: a mini-review,” Wiener Medizinische Wochenschrift, vol. 123, pp. 386–391, 2005.
  20. J. J. Park, S. Beckman-Harned, G. Cho, D. Kim, and Hangon Kim, “The current acceptance, accessibility and recognition of Chinese and Ayurvedic medicine in the United States in the public, governmental, and industrial sectors,” Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 405–408, 2012. View at Publisher · View at Google Scholar
  21. J. Wang and X. J. Xiong, “Control strategy on hypertension in Chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 284847, 6 pages, 2012. View at Publisher · View at Google Scholar
  22. H. Xu and K. J. Chen, “Making evidence-based decisions in the clinical practice of integrative medicine,” Chinese Journal of Integrative Medicine, vol. 16, no. 6, pp. 483–485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Y. Liu and K. J. Chen, “Convergence: the tradition and the modern,” Chinese Journal of Integrative Medicine, vol. 18, no. 3, pp. 164–165, 2012. View at Publisher · View at Google Scholar
  24. P. Williamson and M. Clarke, “The COMET (Core Outcome Measures in Effectiveness Trials) Initiative: its role in improving Cochrane Reviews,” Cochrane Database of Systematic Reviews, vol. 5, Article ID ED000041, 2012.
  25. R. M. Smyth, J. J. Kirkham, A. Jacoby, D. G. Altman, C. Gamble, and P. R. Williamson, “Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists,” BMJ, vol. 342, Article ID c7153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement,” PLOS Medicine, vol. 6, no. 7, Article ID e1000097, 2009.
  27. H. Wang, H. C. Shang, J. H. Zhang et al., “Niuhuang Jiangya preparation for treatment of essential hypertension: a systematic review,” Liaoning Zhong Yi Za Zhi, vol. 35, no. 5, pp. 649–652, 2008 (Chinese).
  28. Y. X. Hu, Quantitative analysis of clinical controlled trials of traditional Chinese medicine and systematic evaluation of randomized controlled trials involving traditional Chinese medicine for essential hypertension, [M.S. thesis], Guangzhou University of Chinese Medicine, Guangzhou, China, 2009.
  29. Y. Ren, A. H. Ou, X. Z. Lin, and Y. R. Lao, “Meta-analysis of traditional Chinese medicine for essential hypertension,” Shanxi Zhong Yi, vol. 27, no. 7, pp. 794–796, 2006 (Chinese).
  30. D. X. Dong, S. L. Yao, N. Yu, and B. Yang, “Systematic review and meta-analysis of Tianma Gouteng Yin combined with enalapril for essential hypertension,” Zhongguo Zhong Yi Ji Zheng, vol. 20, no. 5, pp. 762–764, 2011 (Chinese).
  31. H. W. Zhang, J. Tong, G. Zhou, H. Jia, and J. Y. Jiang, “Tianma Gouteng Yin formula for treating primary hypertension,” Cochrane Database of Systematic Reviews, no. 6, Article ID CD008166, 2012. View at Publisher · View at Google Scholar
  32. W. J. Xu and Y. L. Li, “Systematic review of clinical evidence about calm the liver and subdue yang therapy on the hypertension disease with syndrome of upper hyperactivity of liver yang,” Zhonghua Zhong Yi Yao Za Zhi, vol. 27, no. 3, pp. 736–739, 2012 (Chinese).
  33. M. Shi and Y. H. Zhang, “Systematic review of replenishing kidney qi method for essential hypertension with kidney qi deficiency syndrome,” Shandong Zhong Yi Za Zhi, vol. 31, no. 4, pp. 236–238, 2012 (Chinese).
  34. L. Liu and Y. L. Li, “Systematic review on treatment of essential hypertension from spleen and kidney deficiency,” Zhonghua Zhong Yi Yao Za Zhi, vol. 26, no. 8, pp. 1700–1703, 2011 (Chinese).
  35. D. N. Li and C. H. Yang, “Effects of Chinese medicine on elderly isolated systolic hypertension: a meta-analysis,” Liaoning Zhong Yi Za Zhi, vol. 39, no. 5, pp. 812–815, 2012 (Chinese).
  36. S. H. Han, Evaluation of integrated Chinese and western medicine in treatment of hypertension in the elderly and their life quality, [M.S. thesis], China Academy of Chinese Medical Sciences, Beijing, China, 2011.
  37. J. P. T. Higgins and S. Green, “Cochrane handbook for systematic reviews of interventions,” version 5. 1. 0, The Cochrane Collaboration, 2009, http://www.cochrane-handbook.org/.
  38. M. Clarke, “Standardising outcomes for clinical trials and systematic reviews,” Trials, vol. 8, article no. 39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Veitch, “The science of outcomes: how far have we come?” http://blogs.plos.org/speakingofmedicine/2011/07/15/the-science-of-outcomes-how-far-have-we-come/.
  40. K. J. Chen, “Clinical service of Chinese medicine,” Chinese Journal of Integrative Medicine, vol. 14, no. 3, pp. 163–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Chan, “Some aspects of toxic contaminants in herbal medicines,” Chemosphere, vol. 52, no. 9, pp. 1361–1371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Zhang, J. B. Yan, X. M. Liu et al., “Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective,” Journal of Ethnopharmacology, vol. 140, no. 3, pp. 519–525, 2012. View at Publisher · View at Google Scholar
  43. H. Xu and K. J. Chen, “Herb-drug interaction: an emerging issue of integrative medicine,” Chinese Journal of Integrative Medicine, vol. 16, no. 3, pp. 195–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Wang, R. van der Heijden, S. Spruit et al., “Quality and safety of Chinese herbal medicines guided by a systems biology perspective,” Journal of Ethnopharmacology, vol. 126, no. 1, pp. 31–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Melchart, K. Linde, S. Hager, D. Shaw, and R. Bauer, “Liver enzyme elevations in patients treated with traditional Chinese medicine,” Journal of the American Medical Association, vol. 282, no. 1, pp. 28–29, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Green, J. P. T. Higgins, P. Alderson, et al., Cochrane Handbook, version 5.0.1, The Cochrane Library, 2008.
  47. The Cochrane Collaboration, “Cochrane reviews,” 2011, http://www.cochrane.org/cochrane-reviews/.
  48. J. Luo and H. Xu, “Outcome measures of Chinese herbal medicine for coronary heart disease: an overview of systematic reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 927392, 9 pages, 2012. View at Publisher · View at Google Scholar
  49. Y. Qiu, H. Xu, and D. Z. Shi, “Traditional Chinese herbal products for coronary heart disease: an overview of Cochrane Reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 417387, 2012. View at Publisher · View at Google Scholar
  50. J. Hu, J. H. Zhang, W. Zhao, Y. L. Zhang, L. Zhang, and H. C. Shang, “Cochrane systematic reviews of Chinese herbal medicines: an overview,” PLoS One, vol. 6, no. 12, Article ID e28696, 2011. View at Publisher · View at Google Scholar
  51. B. Ma, J. Guo, G. Qi et al., “quality and reporting characteristics of systematic reviews of traditional Chinese medicine interventions published in Chinese journals,” PLoS One, vol. 6, no. 5, Article ID e20185, 2011. View at Publisher · View at Google Scholar
  52. J. He, L. Du, G. Liu et al., “Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews,” Trials, vol. 12, article no. 122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Junhua, S. Hongcai, G. Xiumei et al., “Methodology and reporting quality of systematic review/meta-analysis of traditional Chinese medicine,” Journal of Alternative and Complementary Medicine, vol. 13, no. 8, pp. 797–805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Wang, K. W. Yao, X. C. Yang et al., “Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 714805, 7 pages, 2012. View at Publisher · View at Google Scholar
  55. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials,” PLoS Medicine, vol. 7, no. 3, Article ID e1000251, 2010. View at Publisher · View at Google Scholar · View at Scopus